1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wang JB, Fan JH, Liang H, Li J, Xiao HJ,
Wei WQ, Dawsey SM, Qiao YL and Boffetta P: Attributable causes of
esophageal cancer incidence and mortality in China. PLoS One.
7:e422812012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Burrows WM: Gastrointestinal function and
related problems following esophagectomy. Semin Thorac Cardiovasc
Surg. 16:142–151. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Xu YW, Peng YH, Chen B, Wu ZY, Wu JY, Shen
JH, Zheng CP, Wang SH, Guo HP, Li EM, et al: Autoantibodies as
potential biomarkers for the early detection of esophageal squamous
cell carcinoma. Am J Gastroenterol. 109:36–45. 2014. View Article : Google Scholar :
|
5
|
Jiang H, Lin JJ, Su ZZ, Goldstein NI and
Fisher PB: Subtraction hybridization identifies a novel melanoma
differentiation associated gene, mda-7, modulated during human
melanoma differentiation, growth and progression. Oncogene.
11:2477–2486. 1995.PubMed/NCBI
|
6
|
Gupta P, Su ZZ, Lebedeva IV, Sarkar D,
Sauane M, Emdad L, Bachelor MA, Grant S, Curiel DT, Dent P, et al:
mda-7/IL-24: Multifunctional cancer-specific apoptosis-inducing
cytokine. Pharmacol Ther. 111:596–628. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Caudell EG, Mumm JB, Poindexter N,
Ekmekcioglu S, Mhashilkar AM, Yang XH, Retter MW, Hill P, Chada S
and Grimm EA: The protein product of the tumor suppressor gene,
melanoma differentiation-associated gene 7, exhibits
immunostimulatory activity and is designated IL-24. J Immunol.
168:6041–6046. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Fisher PB: Is mda-7/IL-24 a ʻmagic bulletʼ
for cancer? Cancer Res. 65:10128–10138. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Su ZZ, Lebedeva IV, Sarkar D,
Gopalkrishnan RV, Sauane M, Sigmon C, Yacoub A, Valerie K, Dent P
and Fisher PB: Melanoma differentiation associated gene-7,
mda-7/IL-24, selectively induces growth suppression, apoptosis and
radiosensitization in malignant gliomas in a p53-independent
manner. Oncogene. 22:1164–1180. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang J, Fan X, Bao L and Du L:
Construction of eukaryotic expression vector of EGFRi-IL-24
recombinant gene. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi.
27:395–399. 2010.In Chinese. PubMed/NCBI
|
11
|
Sieger KA, Mhashilkar AM, Stewart A,
Sutton RB, Strube RW, Chen SY, Pataer A, Swisher SG, Grimm EA,
Ramesh R, et al: The tumor suppressor activity of MDA-7/IL-24 is
mediated by intracellular protein expression in NSCLC cells. Mol
Ther. 9:355–367. 2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ekmekcioglu S, Ellerhorst JA, Mumm JB,
Zheng M, Broemeling L, Prieto VG, Stewart AL, Mhashilkar AM, Chada
S and Grimm EA: Negative association of melanoma
differentiation-associated gene (mda-7) and inducible nitric oxide
synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression
in melanoma cells. Mol Cancer Ther. 2:9–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zheng M, Bocangel D, Ramesh R, Ekmekcioglu
S, Poindexter N, Grimm EA and Chada S: Interleukin-24 overcomes
temozolo-mide resistance and enhances cell death by down-regulation
of O6-methylguanine-DNA methyltransferase in human
melanoma cells. Mol Cancer Ther. 7:3842–3851. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sauane M, Su ZZ, Gupta P, Lebedeva IV,
Dent P, Sarkar D and Fisher PB: Autocrine regulation of mda-7/IL-24
mediates cancer-specific apoptosis. Proc Natl Acad Sci USA.
105:9763–9768. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chada S, Bocangel D, Ramesh R, Grimm EA,
Mumm JB, Mhashilkar AM and Zheng M: mda-7/IL24 kills pancreatic
cancer cells by inhibition of the Wnt/PI3K signaling pathways:
Identification of IL-20 receptor-mediated bystander activity
against pancreatic cancer. Mol Ther. 11:724–733. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ramesh R, Mhashilkar AM, Tanaka F, Saito
Y, Branch CD, Sieger K, Mumm JB, Stewart AL, Boquoi A, Dumoutier L,
et al: Melanoma differentiation-associated gene 7/interleukin
(IL)-24 is a novel ligand that regulates angiogenesis via the IL-22
receptor. Cancer Res. 63:5105–5113. 2003.PubMed/NCBI
|
17
|
Zheng M, Bocangel D, Doneske B, Mhashilkar
A, Ramesh R, Hunt KK, Ekmekcioglu S, Sutton RB, Poindexter N, Grimm
EA, et al: Human interleukin 24 (MDA-7/IL-24) protein kills breast
cancer cells via the IL-20 receptor and is antagonized by IL-10.
Cancer Immunol Immunother. 56:205–215. 2007. View Article : Google Scholar
|
18
|
Lebedeva IV, Su ZZ, Sarkar D and Fisher
PB: Restoring apoptosis as a strategy for cancer gene therapy:
Focus on p53 and mda-7. Semin Cancer Biol. 13:169–178. 2003.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Su Z, Emdad L, Sauane M, Lebedeva IV,
Sarkar D, Gupta P, James CD, Randolph A, Valerie K, Walter MR, et
al: Unique aspects of mda-7/IL-24 antitumor bystander activity:
Establishing a role for secretion of MDA-7/IL-24 protein by normal
cells. Oncogene. 24:7552–7566. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ma G, Kawamura K, Shan Y, Okamoto S, Li Q,
Namba M, Shingyoji M, Tada Y, Tatsumi K, Hiroshima K, et al:
Combination of adenoviruses expressing melanoma
differentiation-associated gene-7 and chemotherapeutic agents
produces enhanced cyto-toxicity on esophageal carcinoma. Cancer
Gene Ther. 21:31–37. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ma Q, Deng X, Jin B, Zhang Y, Luo D, Song
H, Wang P, Zhang C, Li X, Shi Y, et al: A novel human
interleukin-24 peptide created by computer-guided design
contributes to suppression of proliferation in esophageal squamous
cell carcinoma Eca-109 cells. Oncol Rep. 33:193–200. 2015.
|
22
|
Yang J, Zhang W, Liu K, Jing S, Guo G, Luo
P and Zou Q: Expression, purification, and characterization of
recombinant human interleukin 24 in Escherichia coli. Protein Expr
Purif. 53:339–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Chada S, Mhashilkar AM, Ramesh R, Mumm JB,
Sutton RB, Bocangel D, Zheng M, Grimm EA and Ekmekcioglu S:
Bystander activity of Ad-mda7: Human MDA-7 protein kills melanoma
cells via an IL-20 receptor-dependent but STAT3-independent
mechanism. Mol Ther. 10:1085–1095. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Aggarwal S, Takada Y, Mhashilkar AM,
Sieger K, Chada S and Aggarwal BB: Melanoma
differentiation-associated gene-7/IL-24 gene enhances NF-kappa B
activation and suppresses apoptosis induced by TNF. J Immunol.
173:4368–4376. 2004. View Article : Google Scholar : PubMed/NCBI
|
25
|
Yacoub A, Mitchell C, Hong Y,
Gopalkrishnan RV, Su ZZ, Gupta P, Sauane M, Lebedeva IV, Curiel DT,
Mahasreshti PJ, et al: MDA-7 regulates cell growth and
radiosensitivity in vitro of primary (non-established) human glioma
cells. Cancer Biol Ther. 3:739–751. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Kreis S, Philippidou D, Margue C,
Rolvering C, Haan C, Dumoutier L, Renauld JC and Behrmann I:
Recombinant interleukin-24 lacks apoptosis-inducing properties in
melanoma cells. PLoS One. 2:e13002007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Mumm JB, Ekmekcioglu S, Poindexter NJ,
Chada S and Grimm EA: Soluble human MDA-7/IL-24: Characterization
of the molecular form(s) inhibiting tumor growth and stimulating
monocytes. J Interferon Cytokine Res. 26:877–886. 2006. View Article : Google Scholar
|
28
|
Dash R, Bhutia SK, Azab B, Su ZZ, Quinn
BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, et al:
mda-7/IL-24: A unique member of the IL-10 gene family promoting
cancer-targeted toxicity. Cytokine Growth Factor Rev. 21:381–391.
2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Saeki T, Mhashilkar A, Swanson X, Zou-Yang
XH, Sieger K, Kawabe S, Branch CD, Zumstein L, Meyn RE, Roth JA, et
al: Inhibition of human lung cancer growth following
adenovirus-mediated mda-7 gene expression in vivo. Oncogene.
21:4558–4566. 2002. View Article : Google Scholar : PubMed/NCBI
|
30
|
Tamai H, Miyake K, Yamaguchi H, Takatori
M, Dan K, Inokuchi K and Shimada T: AAV8 vector expressing IL24
efficiently suppresses tumor growth mediated by specific mechanisms
in MLL/AF4-positive ALL model mice. Blood. 119:64–71. 2012.
View Article : Google Scholar
|
31
|
Gu J, Chen X, Xin H, Fang X and Sha X:
Serum-resistant complex nanoparticles functionalized with
imidazole-rich polypeptide for gene delivery to pulmonary
metastatic melanoma. Int J Pharm. 461:559–569. 2014. View Article : Google Scholar
|